Spots Global Cancer Trial Database for Pelvic Drain After Rectal Resection for Mid-low Rectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pelvic Drain After Rectal Resection for Mid-low Rectal Cancer
Official Title: Pelvic Drain After Rectal Resection for Mid-low Rectal Cancer: a Randomised Controlled Trial
Study ID: NCT04573621
Conditions
Study Description
Brief Summary: This RCT aims at assessing the effects of a pelvic drain after total mesorectal excision for mid-low rectal cancer on the rates of pelvic sepsis and anastomotic leaks.
Detailed Description: This is a 2-arm, non-inferiority RCT. Patients undergoing total mesorectal excision for mid-low rectal cancer will be randomly assigned into two groups: * pelvic drain * no pelvic drain. Patients will be followed-up to assess the rates of anastomotic leaks, pelvic sepsis and secondary outcomes.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hospital General Universitario Vall d´Hebron, Barcelona, Barcelona, Spain, Spain
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
